The Israeli biopharmaceutical company will focus on developing drugs to treat schizophrenia and Alzheimer’s psychosis. Read More Start ups | Read More Israel Insider | NOWlej | Read More in Virtual Jerusalem
Recent Posts
The Jerusalem Post
German antisemitism commissioner’s property set on fire, Hamas symbol graffitied nearby
January 5, 2026Venezuela’s energy, mining sectors in focus after Maduro capture – explainer
January 5, 2026Sa’ar meets with UN special coordinator to discuss Hezbollah disarmament, future of Lebanon
January 5, 2026Palo Alto Networks in talks to buy Israeli company Koi Security for $400m
January 5, 2026
YnetNews
Swiss cheese fence: the barrier meant to protect Israelis now lets terrorists in
January 5, 2026Report: Iran’s Khamenei prepared to flee to Russia if unrest escalates
January 5, 2026Canadian actress reignites debate by seeking assisted death after years of mental illness
January 5, 2026Netanyahu struggles to hold coalition as Haredi draft crisis deepens
January 5, 2026
Arutz Sheva
Grenade hurled at Ashkelon homeJanuary 5, 2026
Graffiti spray-painted outside Galei Zahal studiosJanuary 5, 2026
Forces demolish house of terrorist who murdered Mordechai and AvivJanuary 5, 2026
Rabbi Lando: Happy are those arrested for learning TorahJanuary 5, 2026
JTA
Enough with the slogans: How can Israel truly jump-start the long-term rental market?
January 5, 2026Netanyahu pulls the strings while Israel’s center ignores Arab inclusion – opinion
January 5, 2026Dropping the IHRA definition sends the wrong signal to the Jewish community – opinion
January 5, 2026Moscow and Tehran’s new partnership is bad news for the West – opinion
January 5, 2026- January 5, 2026